anti-obesity therapeutics (Genzyme)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameanti-obesity therapeutics (Genzyme)
Drug Alias Namelipase inhibiting polymers (Genzyme)pancreatic lipase inhibiting polymers (Genzyme)GT-316-235
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPancreatic triacylglycerol lipase inhibitors
TargetsPancreatic triacylglycerol lipase
Therapy Area/IndicationsObesityMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGelTex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenzyme CorpGelTex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsObesityMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A